China spend plan for AstraZeneca

18 July 2007
More news

19 July 2007

AstraZeneca expects to process $100 million (£50 million) of spend through its sourcing centre in China by 2010.

The pharmaceutical firm told SM it will begin sourcing and manufacturing most of its active pharmaceutical ingredients in China and India over the next five to 10 years.

The company established sourcing centres in Asia earlier this year and confirmed it intended to move production away from its current locations in Macclesfield in the UK and Plankstadt in Germany. The group currently has an annual purchasing spend of $9 billion (£4 billion).

Marc Jones, vice-president of external global sourcing, said the company would still have manufacturing capability in the medium term in Avlon, near Bristol, Dunkirk and Sweden, though this plant is being downsized.

"Our plans in China and India are embryonic but we see this as the way forward," he said.


Swindon, Wiltshire
upto £40K base (+ Paid overtime and corporate benefits)
Honda Manufacturing Ltd
Kew gardens, Richmond upon Thames, London (Greater)
£37,000 - £42,500 per annum pro rata, depending on skills and experience
Kew Royal Botanic Gardens
CIPS Knowledge
Find out more with CIPS Knowledge:
  • best practice insights
  • guidance
  • tools and templates